Role of neuronal NO synthase in regulating vascular superoxide levels and mitogen-activated protein kinase phosphorylation

Cardiovascular Research

Volumn 81, Issue 2, 2009, Pages 389-399

  Zhang, Guo Xing ^a   Kimura, Shoji ^b   Murao, Koji ^b   Shimizu, Juichiro ^a   Matsuyoshi, Hiroko ^a   Takaki, Miyako ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

Angiotensin II; Mitogen activated protein kinase (MAPK); Neuronal nitric oxide synthase; Superoxide

Indexed keywords

5,10,15,20 TETRAKIS(4 SULFONTOPHENYL)PORPHYRINATO IRON COMPLEX; ANGIOTENSIN II; APOCYNIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; N5 (1 IMINO 3 BUTENYL)ORNITHINE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; OXYPURINAL; PEROXYNITRITE; SUPEROXIDE; TEMPOL; UNCLASSIFIED DRUG; XANTHINE OXIDASE INHIBITOR;

ANIMAL CELL; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; DENSITOMETRY; GENE DELETION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING; WILD TYPE;

ACETOPHENONES; ANGIOTENSIN II; ANIMALS; CELLS, CULTURED; CYCLIC N-OXIDES; MALE; METALLOPORPHYRINS; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASES; NITRIC OXIDE SYNTHASE TYPE I; ORNITHINE; OXYPURINOL; PHOSPHORYLATION; SPIN LABELS; SUPEROXIDES; XANTHINE OXIDASE;

EID: 58449132260     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvn304     Document Type: Article

References (30)

1. Fleming I, Kohlstedt K, Busse R. The tissue renin-angiotensin system and intracellular signalling. Curr Opin Nephrol Hypertens 2006;15:8-13.
2. Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 2000;52:11-34.
3. Griendling KK, Ushio-Fukai M. Reactive oxygen species as mediators of angiotensin II signaling. Cardiovasc Res 2000;91:21-27.
4. Wolf G. Role of reactive oxygen species in angiotensin II-mediated renal growth, differentiation, and apoptosis. Antioxid Redox Signal 2005;7:1337-1345.
5. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, Griendling KK. Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Cir Res 2002;91:406-413.
6. Lassegue B, Sorescu D, Szocs K, Yin Q, Akers M, Zhang Y et al. Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 2001;88:888-894.
7. Zhang GX, Lu XM, Kimura S, Nishiyama A. Role of mitochondria in angiotensin II-induced reactive oxygen species and mitogen-activated protein kinase activation. Cardiovasc Res 2007;76:204-212.
8. Kimura S, Zhang GX, Nishiyama A, Shokoji T, Yao L, Fan YY et al. Mitochondria-derived reactive oxygen species and vascular MAP kinases: comparison of angiotensin II and diazoxide. Hypertension 2005;45:438-444.
9. Kimura S, Zhang GX, Nishiyama A, Shokoji T, Yao L, Fan YY et al. Role of NAD(P)H oxidase- and mitochondria-derived reactive oxygen species in cardioprotection of ischemic reperfusion injury by angiotensin II. Hypertension 2005;45:860-866.
10. Zhang GX, Nagai Y, Nakagawa T, Miyanaka H, Fujisawa Y, Nishiyama A et al. Involvement of endogenous nitric oxide in angiotensin II-induced activation of vascular mitogen-activated protein kinases. Am J Physiol Heart Circ Physiol 2007;293:H2403-H2408.
11. Pinzar E, Wang T, Garrido MR, Xu W, Levy P, Bottari SP. Angiotensin II induces tyrosine nitration and activation of ERK1/2 in vascular smooth muscle cells. FEBS Lett 2005;579:5100-5104.
12. Sun J, Druhan LJ, Zweier JL. Dose dependent effects of reactive oxygen and nitrogen species on the function of neuronal nitric oxide synthase. Arch Biochem Biophys 2008;471:126-133.
13. Chalupsky K, Cai H. Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 2005;102:9056-9061.
14. Bredt DS, Snyder SH. Nitric oxide: a physiological messenger molecule. Annu Rev Biochem 1994;63:175-195.
15. Harrison DG. Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 1997;100:2153-2157.
16. Morishita T, Tsutsui M, Shimokawa H, Horiuchi M, Tanimoto A, Suda O et al. Vasculoprotective roles of neuronal nitric oxide synthase. FASEB J 2002;16:1994-1996.
17. Nakata S, Tsutsui M, Shimokawa H, Tamura M, Tasaki H, Morishita T et al. Vascular neuronal NO synthase is selectively upregulated by platelet-derived growth factor: involvement of the MEK/ERK pathway. Arterioscler Thromb Vasc Biol 2005;25:2502-2508.
18. Boulanger CM, Heymes C, Benessiano J, Geske RS, Lévy BI, Vanhoutte PM. Neuronal nitric oxide synthase is expressed in rat vascular smooth muscle cells: activation by angiotensin II in hypertension. Circ Res 1998;83:1271-1278.
19. Khan SA, Lee K, Minhas KM, Gonzalez DR, Raju SV, Tejani AD et al. Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation-contraction coupling. Proc Natl Acad Sci USA 2004;101:15944-15948.
20. Kase H, Hashikabe Y, Uchida K, Nakanishi N, Hattori Y. Supplementation with tetrahydrobiopterin prevents the cardiovascular effects of angiotensin II-induced oxidative and nitrosative stress. J Hypertens 2005;23:1375-1382.
21. McGuire DK, Winterfield JR, Rytlewski JA, Ferrannini E. Blocking the renin-angiotensin- aldosterone system to prevent diabetes mellitus. Diab Vasc Dis Res 2008;5:59-66.
22. Hammoud RA, Vaccari CS, Nagamia SH, Khan BV. Regulation of the renin-angiotensin system in coronary atherosclerosis: a review of the literature. Vasc Health Risk Manag 2007;3:937-945.
23. Kanai AJ, Pearce LL, Clemens PR, Birder LA, VanBibber MM, Choi SY. Identification of a neuronal nitric oxide synthase in isolated cardiac mitochondria using electrochemical detection. Proc Natl Acad Sci USA 2001;98:14126-14131.
24. Elfering SL, Sarkela TM, Giulivi C. Biochemistry of mitochondrial nitricoxide synthase. J Biol Chem 2002;277:38079-38086.
25. Xu KY, Huso DL, Dawson TM, Bredt DS, Becker LC. Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proc Natl Acad Sci USA 1996;96:657-662.
26. Zhang DX, Gutterman DD. Mitochondrial reactive oxygen species-mediated signaling in endothelial cells. Am J Physiol Heart Circ Physiol 2007;292:H2023-H2031.
27. Ferdinandy P, Schulz R. Nitric oxide, superoxide, and peroxynitrite in myocardio ischemia-reperfusion injury and preconditioning. Br J Pharmacol 2003;138:532-543.
28. Yasmin W, Strynadka KD, Schulz R. Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts. Cardiovasc Res 1997;33:422-432.
29. + pump in cardiac myocytes. Am J Physiol Cell Physiol 2008;294:C572-C578.
30. 2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. J Biol Chem 1998;273: 25804-25808.